León-Román Juan, Agraz Irene, Vergara Ander, Ramos Natalia, Toapanta Nestor, García-Carro Clara, Gabaldón Alejandra, Bury Roxana, Bermejo Sheila, Bestard Oriol, Soler María José
Vall d'Hebron University Hospital, Department of Nephrology, Barcelona, Spain.
Clinico San Carlos University Hospital, Department of Nephrology, Madrid, Spain.
Clin Kidney J. 2022 Mar 14;15(9):1698-1704. doi: 10.1093/ckj/sfac079. eCollection 2022 Sep.
Novel coronavirus disease infection (coronavirus disease 2019, COVID-19) was declared a global pandemic in March 2020 and since then has become a major public health problem. The prevalence of COVID-19 infection and acute kidney injury (AKI) is variable depending on several factors such as race/ethnicity and severity of illness. The pathophysiology of renal involvement in COVID-19 infection is not entirely clear, but it could be in part explained by the viral tropism in the kidney parenchyma. AKI in COVID-19 infection can be either by direct invasion of the virus or as a consequence of immunologic response. Diverse studies have focused on the effect of COVID-19 on glomerulonephritis (GN) patients or the 'novo' GN; however, the effect of COVID-19 in acute tubulointerstitial nephritis (ATIN) has been scarcely studied. In this article, we present five cases with different spectrums of COVID-19 infection and ATIN that may suggest that recent diagnosis of ATIN is accompanied by a worse clinical prognosis in comparison with long-term diagnosed ATIN.
新型冠状病毒病感染(冠状病毒病2019,COVID-19)于2020年3月被宣布为全球大流行疾病,自那时起已成为一个主要的公共卫生问题。COVID-19感染和急性肾损伤(AKI)的患病率因种族/民族和疾病严重程度等多种因素而异。COVID-19感染时肾脏受累的病理生理学尚不完全清楚,但部分原因可能是病毒对肾实质的嗜性。COVID-19感染中的AKI可能是病毒直接侵袭所致,也可能是免疫反应的结果。众多研究聚焦于COVID-19对肾小球肾炎(GN)患者或“新发”GN的影响;然而,COVID-19在急性肾小管间质性肾炎(ATIN)中的作用鲜有研究。在本文中,我们展示了5例COVID-19感染和ATIN不同表现的病例,这可能表明与长期诊断的ATIN相比,近期诊断的ATIN临床预后更差。